N-FIS was developed to address a critical challenge in healthcare—needle phobia
Express Pharma
APRIL 10, 2025
Currently, we are actively working on co-packaging collaborations with pharma companies to drive adoption across various medical sectors, including paediatrics, infertility treatments, and broader healthcare applications. billion in 2028, growing at a compound annual growth rate (CAGR) of 14.16 What are the projections?
Let's personalize your content